跳至主要内容
临床试验/TCTR20200814009
TCTR20200814009已完成3 期

Efficacy and tolerability of 20% aluminum sesquichlorohydrate versus 20% aluminum chloride for the treatment of axillary hyperhidrosis: a randomized controlled trial

Faculty of Medicine, Srinakharinwirot University0 个研究点目标入组 20 人开始时间: 2020年8月14日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • The participants were 18 to 60 years of age with Sweating Intensity Visual Scale (SIVS)by
  • iodine-starch testof 2 or higher, and HDSS of grade 2 or higher for at least 6 months.

排除标准

  • d history of allergy or sensitivity to aluminum salts, previous axillary treatments with
  • topical antiperspirant or anticholinergic medication within 2 weeks of the trial, treatment with
  • energy-based device in axillae within 6 months, treatment with botulinum toxin A or iontophoresis
  • within 12 months, and active skin diseases, for example, dermatological infections or eczema in
  • the treatment area. Use of OTC antiperspirant products were advised to be stopped 24 hours prior
  • to the day of screening, and during the study

研究者

发起方
Faculty of Medicine, Srinakharinwirot University

相似试验